(NASDAQ: HCAT) Health Catalyst's forecast annual revenue growth rate of 7.87% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 13.45%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.23%.
Health Catalyst's revenue in 2024 is $295,938,000.On average, 7 Wall Street analysts forecast HCAT's revenue for 2024 to be $18,053,510,366, with the lowest HCAT revenue forecast at $17,982,356,315, and the highest HCAT revenue forecast at $18,136,377,018. On average, 7 Wall Street analysts forecast HCAT's revenue for 2025 to be $20,095,778,040, with the lowest HCAT revenue forecast at $19,811,278,961, and the highest HCAT revenue forecast at $20,393,980,861.
In 2026, HCAT is forecast to generate $22,561,397,676 in revenue, with the lowest revenue forecast at $22,561,397,676 and the highest revenue forecast at $22,561,397,676.